Quality statement 4: Preoperative treatment of rectal cancer

Quality statement

People with rectal cancer are offered a preoperative treatment strategy appropriate to their stage of local disease recurrence.

Quality measure

Structure

Evidence of local arrangements, including written clinical protocols, to ensure people with rectal cancer are offered a preoperative treatment strategy appropriate to their stage of local disease recurrence.

Data source: Local data collection.

Process

Proportion of people with rectal cancer who are offered a preoperative treatment strategy appropriate to their stage of local disease recurrence.

Numerator – the number of people in the denominator who are offered a preoperative treatment strategy appropriate to their stage of local disease recurrence.

Denominator – the number of people with rectal cancer.

Data source: Local data collection.

Outcomes

a) Proportion of people with rectal cancer with local disease recurrence.

Data source: National Bowel Cancer Audit and local data collection.

b) Proportion of people with rectal cancer with circumferential resection margin.

Data source: National Bowel Cancer Audit and local data collection.

What the quality statement means for different audiences

Service providers ensure systems are in place for people with rectal cancer to be offered a preoperative treatment strategy appropriate to their stage of local disease recurrence.

Healthcare professionals offer people with rectal cancer a preoperative treatment strategy appropriate to their stage of local disease recurrence.

Commissioners ensure they commission services that offer people with rectal cancer a preoperative treatment strategy appropriate to their stage of local disease recurrence.

People with rectal cancer are offered treatment before surgery that takes into account the likelihood of the cancer returning.

Source guidance

Colorectal cancer (2020) NICE guideline NG151, recommendations 1.3.2 and 1.3.3